Clinical Trial Update: CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers] [Phase 1]

View source ↗

Summary

Phase I, single-arm, open-label dose-escalation study to evaluate the safety and tolerability of Orialpha (BD-C) in healthy adult volunteers; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Orialpha (BD-C)

Snippet

Sponsor: Oriplantee Company Limited | Conditions: Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult Volunteers, Breast Cancer | Phase 1 | Status: COMPLETED